Shaare Zedek Medical Center
Jerusalem, Israel
NCT Number: NCT03966534
A randomized partially controlled study to examine the effect of blood diversion into a heparin lithium tube on the incidence of blood culture contamination.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Jerusalem, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diversion of initial blood obtained at venipuncture to biochemistry tube in order to try and reduce incidence of blood culture contamination
Time frame: up to 7 days from obtaining blood culture
Growth of bacteria defined as blood culture contaminants (for example coagulase negative staphylococci in one bottle only).
Time frame: up to 3 months from arrival
Length of stay from arrival at Emergency room until discharge in hours
Shaare Zedek Medical Center
Other
A Randomized Controlled Study of Blood Test Draw Order to Reduce Blood Culture Contamination
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04573894
Bacteremia, Bacterial Infections
Nancy, France
View Trial DetailsNCT06806709
Blood Culture Contamination, Infection
Caboolture, Queensland, Australia
View Trial Details